Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ferric maltol (Accrufer) (2 trials)
ranibizumab (lucentis) (1 trial)
Anemia (Phase 3)
Anemia, Iron-Deficiency (Phase 4)
Heart Failure (Phase 4)
Hypertension (Phase 3)
Hypertension, Pulmonary (Phase 3)
Melanoma (Phase 4)
Trials (3 total)
Trial APIs (2 total)